Weinberg Marc S, Criswell Hugh E, Powell Sara K, Bhatt Aadra P, McCown Thomas J
UNC Gene Therapy Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
Bowles Center for Alcohol Studies, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA; Department of Psychiatry, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
Mol Ther. 2017 Apr 5;25(4):928-934. doi: 10.1016/j.ymthe.2017.01.016. Epub 2017 Feb 13.
Recent advances suggest that in vivo reprogramming of endogenous cell populations provides a viable alternative for neuron replacement. Astrocytes and oligodendrocyte precursor cells can be induced to transdifferentiate into neurons in the CNS, but, in these instances, reprogramming requires either transgenic mice or retroviral-mediated gene expression. We developed a microRNA (miRNA)-GFP construct that in vitro significantly reduced the expression of polypyrimidine tract-binding protein, and, subsequently, we packaged this construct in a novel oligodendrocyte preferring adeno-associated virus vector. Ten days after rat striatal transduction, the vast majority of the GFP-positive cells were oligodendrocytes, but 6 weeks to 6 months later, the majority of GFP-positive cells exhibited neuronal morphology and co-localized with the neuronal marker NeuN. Patch-clamp studies on striatal slices established that the GFP-positive cells exhibited electrophysiological properties indicative of mature neurons, such as spontaneous action potentials and spontaneous inhibitory postsynaptic currents. Also, 3 months after striatal vector administration, GFP-positive terminals in the ipsilateral globus pallidus or substantia nigra retrogradely transported fluorescent beads back to GFP-positive striatal cell bodies, indicating the presence of functional presynaptic terminals. Thus, this viral vector approach provides a potential means to harness resident oligodendrocytes as an endogenous source for in vivo neuronal replacement.
近期进展表明,内源性细胞群体的体内重编程为神经元替代提供了一种可行的替代方案。星形胶质细胞和少突胶质前体细胞可被诱导在中枢神经系统中转分化为神经元,但在这些情况下,重编程需要转基因小鼠或逆转录病毒介导的基因表达。我们开发了一种微小RNA(miRNA)-绿色荧光蛋白(GFP)构建体,其在体外可显著降低多嘧啶序列结合蛋白的表达,随后,我们将该构建体包装在一种新型的、优先感染少突胶质细胞的腺相关病毒载体中。大鼠纹状体转导10天后,绝大多数GFP阳性细胞为少突胶质细胞,但6周后至6个月后,大多数GFP阳性细胞呈现神经元形态,并与神经元标志物NeuN共定位。对纹状体切片进行的膜片钳研究表明,GFP阳性细胞表现出成熟神经元的电生理特性,如自发动作电位和自发抑制性突触后电流。此外,在纹状体注射载体3个月后,同侧苍白球或黑质中的GFP阳性终末将荧光珠逆行运输回GFP阳性的纹状体细胞体,表明存在功能性突触前终末。因此,这种病毒载体方法提供了一种潜在手段,可利用驻留少突胶质细胞作为体内神经元替代的内源性来源。